ID: ALA4172676

Max Phase: Preclinical

Molecular Formula: C9H12Cl2N2

Molecular Weight: 146.19

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1cncc(C#CCN)c1.Cl.Cl

Standard InChI:  InChI=1S/C9H10N2.2ClH/c1-8-5-9(3-2-4-10)7-11-6-8;;/h5-7H,4,10H2,1H3;2*1H

Standard InChI Key:  WFZHNCJXURYQOC-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 146.19

Molecular Weight (Monoisotopic): 146.0844

AlogP: 0.70

#Rotatable Bonds: 0

Polar Surface Area: 38.91

Molecular Species: BASE

HBA: 2

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 2

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 8.52

CX LogP: 0.87

CX LogD: -0.28

Aromatic Rings: 1

Heavy Atoms: 11

QED Weighted: 0.55

Np Likeness Score: -0.24

References

1. Denton TT, Srivastava P, Xia Z, Chen G, Watson CJW, Wynd A, Lazarus P..  (2018)  Identification of the 4-Position of 3-Alkynyl and 3-Heteroaromatic Substituted Pyridine Methanamines as a Key Modification Site Eliciting Increased Potency and Enhanced Selectivity for Cytochrome P-450 2A6 Inhibition.,  61  (16): [PMID:29995408] [10.1021/acs.jmedchem.8b00084]

Source

Source(1):

• Scientific Literature